| Literature DB >> 1827039 |
B T Parys1, S Hamid, R G Thomson.
Abstract
Cyproterone acetate (CPA) is a widely used drug in the treatment of advanced prostatic carcinoma. Although it is generally well tolerated, liver toxicity has been recognised as a complication of long-term use. We report 3 patients with severe hepatocellular damage due to CPA therapy, 2 with fatal fulminant hepatitis.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1827039 DOI： 10.1111/j.1464-410x.1991.tb15142.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331